China’s nascent weight loss drug market is poised for rapid growth ... The Chinese company ran large clinical trials suggesting that in local patients, it appeared just as effective as Lilly’s ...

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.